Malvezzi P - Search Results

1

Belatacept in kidney transplantation and its limitations.

Noble J, Jouve T, Janbon B, Rostaing L, Malvezzi P. Noble J, et al. Among authors: malvezzi p. Expert Rev Clin Immunol. 2019 Apr;15(4):359-367. doi: 10.1080/1744666X.2019.1574570. Epub 2019 Feb 7. Expert Rev Clin Immunol. 2019. PMID: 30676815 Review.

2

Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study.

Buron F, Malvezzi P, Villar E, Chauvet C, Janbon B, Denis L, Brunet M, Daoud S, Cahen R, Pouteil-Noble C, Gagnieu MC, Bienvenu J, Bayle F, Morelon E, Thaunat O. Buron F, et al. Among authors: malvezzi p. PLoS One. 2013;8(1):e53078. doi: 10.1371/journal.pone.0053078. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308138 Free PMC article. Clinical Trial.

3

Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies.

Croze LE, Tetaz R, Roustit M, Malvezzi P, Janbon B, Jouve T, Pinel N, Masson D, Quesada JL, Bayle F, Zaoui P. Croze LE, et al. Among authors: malvezzi p. Transpl Int. 2014 Aug;27(8):775-83. doi: 10.1111/tri.12330. Epub 2014 May 22. Transpl Int. 2014. PMID: 24684741 Free article.

4

Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network.

Lablanche S, Borot S, Thaunat O, Bayle F, Badet L, Morelon E, Thivolet C, Wojtusciszyn A, Frimat L, Kessler L, Penfornis A, Brault C, Colin C, Bosco D, Berney T, Benhamou PY; GRAGIL Network. Lablanche S, et al. Transplantation. 2014 Aug 27;98(4):475-82. doi: 10.1097/TP.0000000000000081. Transplantation. 2014. PMID: 24837539

5

The safety of calcineurin inhibitors for kidney-transplant patients.

Malvezzi P, Rostaing L. Malvezzi P, et al. Expert Opin Drug Saf. 2015 Oct;14(10):1531-46. doi: 10.1517/14740338.2015.1083974. Epub 2015 Sep 2. Expert Opin Drug Saf. 2015. PMID: 26329325 Review.

6

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage.

Malvezzi P, Jouve T, Rostaing L. Malvezzi P, et al. J Nephropathol. 2015 Oct;4(4):110-5. doi: 10.12860/jnp.2015.21. Epub 2015 Oct 1. J Nephropathol. 2015. PMID: 26457257 Free PMC article. Review.

7

HLA-Incompatible Kidney Transplantation--Worth the Risk?

Rostaing LP, Malvezzi P. Rostaing LP, et al. Among authors: malvezzi p. N Engl J Med. 2016 Mar 10;374(10):982-4. doi: 10.1056/NEJMe1601379. N Engl J Med. 2016. PMID: 26962734 No abstract available.

8

Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant.

Malvezzi P, Jouve T, Rostaing L. Malvezzi P, et al. Exp Clin Transplant. 2016 Aug;14(4):361-6. doi: 10.6002/ect.2015.0292. Epub 2016 Apr 4. Exp Clin Transplant. 2016. PMID: 27041365 Free article. Review.

9

Place of mTOR inhibitors in management of BKV infection after kidney transplantation.

Jouve T, Rostaing L, Malvezzi P. Jouve T, et al. Among authors: malvezzi p. J Nephropathol. 2016 Jan;5(1):1-7. doi: 10.15171/jnp.2016.01. Epub 2015 Dec 20. J Nephropathol. 2016. PMID: 27047803 Free PMC article. Review.

10

Steroid-Based Therapy and Risk of Infectious Complications.

Rostaing L, Malvezzi P. Rostaing L, et al. Among authors: malvezzi p. PLoS Med. 2016 May 24;13(5):e1002025. doi: 10.1371/journal.pmed.1002025. eCollection 2016 May. PLoS Med. 2016. PMID: 27218466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters